Feinberg partnered with Nature Genetics and Nature Medicine to host the Chicago Science 2019: Epigenetics and Genome Editing conference.
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
The structure of spherical nucleic acids has the potential to improve the effectiveness of vaccines as well as cancer immunotherapies, according to a new study.
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.